RE: Director's Talk interview7 Feb 2024 09:15
While delighted to hear of our "partners" in the agreement, I am underwhelmed with the lack of positive effect on the SP. Sadly, it always seems to be this way now, as if some strange force is subduing the price??
Having listened to the Director's Talk interview, initially all I heard was next few months, next few months, next few months....... Although a crumb of comfort in the suggestion they have been conservative in their spending of remaining capital.
With the 50p and £1 nutters out in full force, to provide some balance here's what I read into the situation.
MSC trial will not commence in Q2 and depending on further delays maybe not this year.
Moroccan client??? will request further testing before committing to a commercial supply contract. Again not by mid-year.
Utah/Valkor, continues to move at snail's pace, no funds from there first half of year.
I seriously hope they have more or less agreed II or Investment Bank funding of at least £6m as that's what I believe will be required to get to commerciality. Without some really positive news in the next few weeks, we'll be lucky to make it to 10p this year??
I'll be delighted to be proved wrong though!!!